Active substance
Cyproheptadine
- SFDA 3
- US FDA 42
- Health Canada 3
- US price lines 3
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PERIACTIN 4MG TABLETS | 4 mg | Tablet · Oral use | 20 Blister | SAR 5.20 | NCE · Prescription | Algorithm SAL | Suspended |
| CIPTADINE TAB 4MG | 4 mg | Tablet · Oral use | 20 Blister | SAR 2.70 | Generic · Prescription | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
| PERIACTIN | 4 mg | Tablet · Oral use | 20 Blister | SAR 6.85 | NCE · Prescription | MERCK SHARP & DOHME | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | CHARTWELL RX | Prescription | 26 May 1983 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | MOUNTAIN | Prescription | 30 Sep 2003 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | KENTON | Prescription | 30 May 2006 |
| CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML | syrup · oral | RISING | Prescription | 28 Jun 2006 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | INGENUS PHARMS LLC | Prescription | 23 Sep 2015 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | APPCO | Prescription | 29 Nov 2016 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | RISING | Prescription | 31 Jan 2017 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | ZYDUS PHARMS | Prescription | 19 May 2017 |
| CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML | syrup · oral | CHARTWELL MOLECULAR | Prescription | 13 Jul 2017 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | STRIDES PHARMA INTL | Prescription | 11 Apr 2018 |
| CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML | syrup · oral | ST JOHN PHARM | Prescription | 16 Oct 2018 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | REGCON HOLDINGS | Prescription | 12 Apr 2019 |
| CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML | syrup · oral | QUAGEN | Prescription | 22 May 2019 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | QUAGEN | Prescription | 24 Feb 2021 |
| CYPROLARA | 2MG | tablet · oral | QUAGEN | Prescription | 24 Feb 2021 |
| PERIACTIN | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | MERCK | Discontinued | 17 Oct 1961 |
| PERIACTIN | 2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | syrup · oral | MERCK | Discontinued | 30 Mar 1962 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | MYLAN | Discontinued | 23 Apr 1979 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | HERITAGE PHARMA | Discontinued | 10 Jan 1980 |
| CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | syrup · oral | ACTAVIS MID ATLANTIC | Discontinued | 16 Apr 1980 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | KV PHARM | Discontinued | 14 Oct 1980 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | CHARTWELL RX | Discontinued | 24 Feb 1981 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | SUPERPHARM | Discontinued | 18 May 1981 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 9 Jul 1981 |
| CYPROHEPTADINE HYDROCHLORIDE | 4MG | tablet · oral | WATSON LABS | Discontinued | 14 Sep 1981 |
17 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| EURO-CYPROHEPTADINE 2MG/5ML | 02466732 | 2 MG / 5 ML | SYRUP · ORAL | EURO-PHARM INTERNATIONAL CANADA INC |
| JAMP-CYPROHEPTADINE | 02332248 | 4 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| MAR-CYPROHEPTADINE | 02533065 | 4 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CYPROHEPTADINE 2 MG/5 ML SOLN | $0.04186 | per ML | 23 Sep 2026 |
| US NADAC | CYPROHEPTADINE 2 MG/5 ML SYRUP | $0.04186 | per ML | 23 Sep 2026 |
| US NADAC | CYPROHEPTADINE 4 MG TABLET | $0.06787 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Cyproheptadine 4mg tablets | £5.99 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Cyproheptadine
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.